You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
Clinical Development of a Therapeutic Agent for COPD
SBC: BIOMARCK PHARMACEUTICALS, LTD Topic: NHLBIDESCRIPTION provided by applicant Hypersecretion of mucus into the respiratory airways is a major contributing factor in several lung diseases including chronic pulmonary disease COPD asthma cystic fibrosis allergic rhinitis and bronchiectasis Despite the obvious medical importance there presently are no effective therapies to control excess mucus secretion in these diseases and very ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Improved diagnostic and monitoring assays for thyroid cancer
SBC: Soymeds Inc Topic: NCIDESCRIPTION provided by applicant Thyroid cancer is the most common type of endocrine malignancy New thyroid cancers patients are identified daily and most patients live for decades following diagnosis Thyroglobulin TG levels in the sera or in fine needle biopsies of thyroid cancer patients are routinely quantified using various agency approved e g FDA immunoassays for diagnostic and p ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Novel Manufacturing Processes for Tissue Engineered Vascular Grafts
SBC: HUMACYTE, INC. Topic: NHLBIDESCRIPTION provided by applicant This Phase IIB SBIR application is responsive to NHLBI RFA HL andquot NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart Lung Blood and Sleep Disorders and Diseases R andquot This RFA solicits work on andquot basic applied and clinical research on all product and service development related to the ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
MINDFULNESS BASED SUBSTANCE ABUSE PREVENTION PROGRAM FOR ADOLESCENTS WITH FASD
SBC: Innovation Research And Training, Inc. Topic: NICHDAdolescents with Fetal Alcohol Spectrum Disorder FASD are at risk for substance use and abuse Given the dearth of interventions designed specifically for adolescents with FASD there exists a need for evidence based preventive intervention programs for this population Thus the goal of the proposed Phase II application is to complete the product development and evaluate the effectiveness of t ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health